Skip to main content
Erschienen in: Clinical and Translational Oncology 12/2012

01.12.2012 | Research Article

Functional and biologic metrics for predicting radiation pneumonitis in locally advanced non-small cell lung cancer patients treated with chemoradiotherapy

verfasst von: Dongqing Wang, Jingyu Zhu, Jinbo Sun, Baosheng Li, Zhongtang Wang, Ling Wei, Yong Yin, Hongfu Sun, Zheng Fu, Xingguo Zhang, Zongwei Huo

Erschienen in: Clinical and Translational Oncology | Ausgabe 12/2012

Einloggen, um Zugang zu erhalten

Abstract

Objective

To study the predictive value of functional and biologic metrics for predicting radiation pneumonitis (RP) in locally advanced non-small cell lung cancer (LANSCLC) patients treated with chemoradiotherapy.

Methods

Between March 2006 and April 2010, 57 LANSCLC patients were enrolled in a prospective study. Fusion of SPECT and computed tomography scans provides perfusion-weighted functional dose–volume histogram (DVH) and associated functional dosimetric parameters. Blood for serum biomarkers—interleukin-6 (IL-6), transforming growth factor-beta1, and superoxide dismutase (SOD)—was drawn pre-RT and then 40 Gy/4 weeks during the treatment. The incidence of RP was related to the functional and biologic metrics. The predictability of predictors was calculated and compared based on the area under receiver-operating characteristic (ROC) curve (AUC).

Results

Relative volumes of functional lung receiving more than a threshold dose of 5–50 Gy at increments of 5 Gy and elevated levels of serum SOD after delivery of 40 Gy/4 weeks were associated with RP (p < 0.05). The best predictive efficacy of SOD was observed for a cutoff value of 56 U/ml, with a sensitivity of 0.80 (95 % CI 0.28–0.99) and a specificity of 0.67 (95 % CI 0.43–0.65) (p = 0.040). Functional DVH provided better predictive outcome (AUC 0.76–0.98) than standard DVH (AUC 0.62–0.86) for patients with poor baseline lung function.

Conclusion

Functional metrics were identified to be better predictors for RP in patients with poor baseline lung function. SOD seemed to be a potential predictor for RP; however, it will need to be further verified using a larger sample size.
Literatur
1.
Zurück zum Zitat Werner-Wasik M, Paulus R (2011) Acute esophagitis and late lung toxicity in concurrent chemoradiotherapy trials in patients with locally advanced non-small-cell lung cancer: analysis of the Radiation Therapy Oncology Group (RTOG) database. Clin Lung Cancer 12:245–251PubMedCrossRef Werner-Wasik M, Paulus R (2011) Acute esophagitis and late lung toxicity in concurrent chemoradiotherapy trials in patients with locally advanced non-small-cell lung cancer: analysis of the Radiation Therapy Oncology Group (RTOG) database. Clin Lung Cancer 12:245–251PubMedCrossRef
2.
Zurück zum Zitat Saitoh JI, Saito Y (2011) Concurrent chemoradiotherapy followed by consolidation chemotherapy with bi-weekly docetaxel and carboplatin for stage III unresectable non-small-cell lung cancer: clinical application of a protocol used in a previous phase II study. Int J Radiat Oncol Biol Phys (Epub ahead of print) Saitoh JI, Saito Y (2011) Concurrent chemoradiotherapy followed by consolidation chemotherapy with bi-weekly docetaxel and carboplatin for stage III unresectable non-small-cell lung cancer: clinical application of a protocol used in a previous phase II study. Int J Radiat Oncol Biol Phys (Epub ahead of print)
3.
Zurück zum Zitat Phernambucq EC, Spoelstra FO (2011) Outcomes of concurrent chemoradiotherapy in patients with stage III non-small-cell lung cancer and significant comorbidity. Ann Oncol 22:132–138PubMedCrossRef Phernambucq EC, Spoelstra FO (2011) Outcomes of concurrent chemoradiotherapy in patients with stage III non-small-cell lung cancer and significant comorbidity. Ann Oncol 22:132–138PubMedCrossRef
4.
Zurück zum Zitat Barriger RB, Fakiris AJ (2010) Dose–volume analysis of radiation pneumonitis in non-small-cell lung cancer patients treated with concurrent cisplatin and etoposide with or without consolidation docetaxel. Int J Radiat Oncol Biol Phys 78:1381–1386PubMedCrossRef Barriger RB, Fakiris AJ (2010) Dose–volume analysis of radiation pneumonitis in non-small-cell lung cancer patients treated with concurrent cisplatin and etoposide with or without consolidation docetaxel. Int J Radiat Oncol Biol Phys 78:1381–1386PubMedCrossRef
5.
Zurück zum Zitat Lind PA, Marks LB (2002) Receiver operating characteristic curves to assess predictors of radiation-induced symptomatic lung injury. Int J Radiat Oncol Biol Phys 54:340–347PubMedCrossRef Lind PA, Marks LB (2002) Receiver operating characteristic curves to assess predictors of radiation-induced symptomatic lung injury. Int J Radiat Oncol Biol Phys 54:340–347PubMedCrossRef
6.
Zurück zum Zitat Rancati T, Ceresoli GL (2003) Factors predicting radiation pneumonitis in lung cancer patients: a retrospective study. Radiother Oncol 67:275–283PubMedCrossRef Rancati T, Ceresoli GL (2003) Factors predicting radiation pneumonitis in lung cancer patients: a retrospective study. Radiother Oncol 67:275–283PubMedCrossRef
7.
Zurück zum Zitat Kocak Z, Borst GR (2007) Prospective assessment of dosimetric/physiologic-based models for predicting radiation pneumonitis. Int J Radiat Oncol Biol Phys 67:178–186PubMedCrossRef Kocak Z, Borst GR (2007) Prospective assessment of dosimetric/physiologic-based models for predicting radiation pneumonitis. Int J Radiat Oncol Biol Phys 67:178–186PubMedCrossRef
8.
Zurück zum Zitat Shi A, Zhu G (2010) Analysis of clinical and dosimetric factors associated with severe acute radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent chemotherapy and intensity-modulated radiotherapy. Radiat Oncol 5:35PubMedCrossRef Shi A, Zhu G (2010) Analysis of clinical and dosimetric factors associated with severe acute radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent chemotherapy and intensity-modulated radiotherapy. Radiat Oncol 5:35PubMedCrossRef
9.
Zurück zum Zitat Novakova-Jiresova A, Van Gameren MM (2004) Transforming growth factor-beta plasma dynamics and post-irradiation lung injury in lung cancer patients. Radiother Oncol 71:183–189PubMedCrossRef Novakova-Jiresova A, Van Gameren MM (2004) Transforming growth factor-beta plasma dynamics and post-irradiation lung injury in lung cancer patients. Radiother Oncol 71:183–189PubMedCrossRef
10.
Zurück zum Zitat Zhao L, Sheldon K (2008) The predictive role of plasma TGF-beta1 during radiation therapy for radiation-induced lung toxicity deserves further study in patients with non-small cell lung cancer. Lung Cancer 59:232–239PubMedCrossRef Zhao L, Sheldon K (2008) The predictive role of plasma TGF-beta1 during radiation therapy for radiation-induced lung toxicity deserves further study in patients with non-small cell lung cancer. Lung Cancer 59:232–239PubMedCrossRef
11.
Zurück zum Zitat Kim JY, Kim YS (2009) The TGF-beta1 dynamics during radiation therapy and its correlation to symptomatic radiation pneumonitis in lung cancer patients. Radiat Oncol 4:59PubMedCrossRef Kim JY, Kim YS (2009) The TGF-beta1 dynamics during radiation therapy and its correlation to symptomatic radiation pneumonitis in lung cancer patients. Radiat Oncol 4:59PubMedCrossRef
12.
Zurück zum Zitat Chen Y, Hyrien O (2005) Interleukin (IL)-1A and IL-6: applications to the predictive diagnostic testing of radiation pneumonitis. Int J Radiat Oncol Biol Phys 62:260–266PubMedCrossRef Chen Y, Hyrien O (2005) Interleukin (IL)-1A and IL-6: applications to the predictive diagnostic testing of radiation pneumonitis. Int J Radiat Oncol Biol Phys 62:260–266PubMedCrossRef
13.
Zurück zum Zitat Arpin D, Perol D (2005) Early variations of circulating interleukin-6 and interleukin-10 levels during thoracic radiotherapy are predictive for radiation pneumonitis. J Clin Oncol 23:8748–8756PubMedCrossRef Arpin D, Perol D (2005) Early variations of circulating interleukin-6 and interleukin-10 levels during thoracic radiotherapy are predictive for radiation pneumonitis. J Clin Oncol 23:8748–8756PubMedCrossRef
14.
Zurück zum Zitat Park EM, Ramnath N (2007) High superoxide dismutase and low glutathione peroxidase activities in red blood cells predict susceptibility of lung cancer patients to radiation pneumonitis. Free Radic Biol Med 42:280–287PubMedCrossRef Park EM, Ramnath N (2007) High superoxide dismutase and low glutathione peroxidase activities in red blood cells predict susceptibility of lung cancer patients to radiation pneumonitis. Free Radic Biol Med 42:280–287PubMedCrossRef
15.
Zurück zum Zitat Mak RH, Alexander BM (2011) A single-nucleotide polymorphism in the MTHFR (methylene tetrahydrofolate reductase) gene is associated with risk of radiation pneumonitis in lung cancer patients treated with thoracic radiation therapy. Cancer (Epub ahead of print) Mak RH, Alexander BM (2011) A single-nucleotide polymorphism in the MTHFR (methylene tetrahydrofolate reductase) gene is associated with risk of radiation pneumonitis in lung cancer patients treated with thoracic radiation therapy. Cancer (Epub ahead of print)
16.
Zurück zum Zitat Yuan X, Liao Z (2009) Single nucleotide polymorphism at re1982073:t869C of the TGFbeta1 gene is associated with the risk of radiation pneumonitis in patients with non-small-cell lung cancer treated with definitive radiotherapy. J Clin Oncol 27:3370–3378PubMedCrossRef Yuan X, Liao Z (2009) Single nucleotide polymorphism at re1982073:t869C of the TGFbeta1 gene is associated with the risk of radiation pneumonitis in patients with non-small-cell lung cancer treated with definitive radiotherapy. J Clin Oncol 27:3370–3378PubMedCrossRef
17.
Zurück zum Zitat Hildebrandt MA, Komaki R (2010) Genetic variants in inflammation-related genes are associated with radiation-induced toxicity following treatment for non-small cell lung cancer. PLoS One 5:e12402PubMedCrossRef Hildebrandt MA, Komaki R (2010) Genetic variants in inflammation-related genes are associated with radiation-induced toxicity following treatment for non-small cell lung cancer. PLoS One 5:e12402PubMedCrossRef
18.
Zurück zum Zitat Rodrigues G, Lock M (2004) Prediction of radiation pneumonitis by dose–volume histogram parameters in lung cancer—a systematic review. Radiother Oncol 71:127–138PubMedCrossRef Rodrigues G, Lock M (2004) Prediction of radiation pneumonitis by dose–volume histogram parameters in lung cancer—a systematic review. Radiother Oncol 71:127–138PubMedCrossRef
19.
Zurück zum Zitat Boersma LJ, Damen EM (1995) Estimation of overall pulmonary function after irradiation using dose–effect relations for local functional injury. Radiother Oncol 36:15–23PubMedCrossRef Boersma LJ, Damen EM (1995) Estimation of overall pulmonary function after irradiation using dose–effect relations for local functional injury. Radiother Oncol 36:15–23PubMedCrossRef
20.
Zurück zum Zitat Marks LB, Spencer DP (1995) The role of three dimensional functional lung imaging in radiation treatment planning: the functional dose–volume histogram. Int J Radiat Oncol Biol Phys 33:65–75PubMedCrossRef Marks LB, Spencer DP (1995) The role of three dimensional functional lung imaging in radiation treatment planning: the functional dose–volume histogram. Int J Radiat Oncol Biol Phys 33:65–75PubMedCrossRef
21.
Zurück zum Zitat Marks LB, Munley MT (1997) Quantification of radiation-induced regional lung injury with perfusion imaging. Int J Radiat Oncol Biol Phys 38:399–409PubMedCrossRef Marks LB, Munley MT (1997) Quantification of radiation-induced regional lung injury with perfusion imaging. Int J Radiat Oncol Biol Phys 38:399–409PubMedCrossRef
22.
Zurück zum Zitat Marks LB, Munley MT (1997) Physical and biological predictors of changes in whole-lung function following thoracic irradiation. Int J Radiat Oncol Biol Phys 39:563–570PubMedCrossRef Marks LB, Munley MT (1997) Physical and biological predictors of changes in whole-lung function following thoracic irradiation. Int J Radiat Oncol Biol Phys 39:563–570PubMedCrossRef
23.
Zurück zum Zitat Seppenwoolde Y, Muller SH (2000) Radiation dose–effect relations and local recovery in perfusion for patients with non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 47:681–690PubMedCrossRef Seppenwoolde Y, Muller SH (2000) Radiation dose–effect relations and local recovery in perfusion for patients with non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 47:681–690PubMedCrossRef
24.
Zurück zum Zitat De Jaeger K, Seppenwoolde Y (2003) Pulmonary function following high-dose radiotherapy of non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 55:1331–1340PubMedCrossRef De Jaeger K, Seppenwoolde Y (2003) Pulmonary function following high-dose radiotherapy of non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 55:1331–1340PubMedCrossRef
25.
Zurück zum Zitat Wang DQ, Li SB (2011) Functional dose–volume histograms for predicting radiation pneumonitis in locally advanced non-small cell lung cancer treated with late-course accelerated hyperfractionated radiotherapy. Exp Ther Med 2:1017–1022PubMed Wang DQ, Li SB (2011) Functional dose–volume histograms for predicting radiation pneumonitis in locally advanced non-small cell lung cancer treated with late-course accelerated hyperfractionated radiotherapy. Exp Ther Med 2:1017–1022PubMed
26.
Zurück zum Zitat Shioyama Y, Jang SY (2007) Preserving functional lung using perfusion imaging and intensity-modulated radiation therapy for advanced-stage non-small cell lung cancer. Int J Radiat Oncol Biol Phys 68:1349–1358PubMedCrossRef Shioyama Y, Jang SY (2007) Preserving functional lung using perfusion imaging and intensity-modulated radiation therapy for advanced-stage non-small cell lung cancer. Int J Radiat Oncol Biol Phys 68:1349–1358PubMedCrossRef
27.
Zurück zum Zitat Trotti A, Colevas AD (2003) CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 13:176–181PubMedCrossRef Trotti A, Colevas AD (2003) CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 13:176–181PubMedCrossRef
28.
Zurück zum Zitat Rübe CE, Palm J (2008) Cytokine plasma levels: reliable predictors for radiation pneumonitis? PLoS One 3:e2898PubMedCrossRef Rübe CE, Palm J (2008) Cytokine plasma levels: reliable predictors for radiation pneumonitis? PLoS One 3:e2898PubMedCrossRef
Metadaten
Titel
Functional and biologic metrics for predicting radiation pneumonitis in locally advanced non-small cell lung cancer patients treated with chemoradiotherapy
verfasst von
Dongqing Wang
Jingyu Zhu
Jinbo Sun
Baosheng Li
Zhongtang Wang
Ling Wei
Yong Yin
Hongfu Sun
Zheng Fu
Xingguo Zhang
Zongwei Huo
Publikationsdatum
01.12.2012
Verlag
Springer Milan
Erschienen in
Clinical and Translational Oncology / Ausgabe 12/2012
Print ISSN: 1699-048X
Elektronische ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-012-0890-3

Weitere Artikel der Ausgabe 12/2012

Clinical and Translational Oncology 12/2012 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.